Latest Headlines

Latest Headlines

Stanford team finds that nanotubes catch a ride with immune cells to reach tumors

One way of bypassing the immune system to deliver drugs to a tumor site is to use the immune system itself as a delivery mechanism. And now researchers have unexpectedly found that nanoparticle-encased drugs injected into mice entered immune cells called monocytes, which then carry the treatment to the correct site.

Nanoballoons 'pop' open to deliver cancer drugs when hit with a red laser

Researchers at the University at Buffalo have put the "pop" into drug delivery by releasing compounds from liposomes called nanoballoons that break open upon being hit with a laser.

My sister, and life science's limits

On a cold January morning in 2013, my big sister, Gretchen, took her last, labored breath and died. She was 46. Over the course of her last month alive, I developed a growing sense of anger and desperation at how her doctors, as well as the drug and diagnostics industries, seemed to have failed her.

Clumps of gold nanoparticles retain heat or drugs to kill cancer cells

Researchers have developed gold nanoparticles that could act as a cancer treatment by heating up and destroying tumor cells when they absorb near-infrared light. And the scientists have made the so-called plasmonic particles in a way that can be reproduced in bulk.

Single microparticle holds 3 different drugs for a cancer 1-2-3 punch

A team of researchers has developed microparticles capable of carrying three different molecules on three different docks, or "patches." They could eventually provide a one-two-three punch against cancer, the researchers say.

Nanoparticles deliver chemotherapy when hit with a targeted light

Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a light-activated delivery system for chemotherapy.

FDA grants humanitarian use for Miltenyi's stem cell transplant device

Miltenyi Biotec said today that the FDA had approved its device for humanitarian use in patients with acute myeloid leukemia (AML) who are getting allogeneic stem cell transplants from matched, related donors. The device, called the CliniMACS CD34 Reagent System, is designed to lower the risk of graft-versus-host disease (GVHD), which is a common complication of this type of transplant.

Rooted delivery vehicles use electric charge and gravity to release drugs over time

Researchers have found that gravity and electrostatics are two important factors at play between cell membranes and drug reservoirs. With these new findings, the scientists hope to create systems that deliver cancer drugs slowly and continuously.

Microlin Bio files for a $25M IPO to advance cancer Dx and Rx treatments

Microlin Bio a fledgling diagnostic and drug developer, filed plans to raise as much as $25 million in a modest initial public offering designed to advance work on tests and related therapies for four different kinds of cancers.

Armed with cancer drugs, white blood cells become cancer-killing sticky bombs

Like any moving target, cancer that has metastasized is notoriously difficult to treat. One of the major hurdles in cancer research is the detection of cancer cells that have spread in the body, but researchers at Cornell have developed a compound that could piggyback on white blood cells and deliver cancer-killing drugs very effectively.